In radioligand therapy, beta-emitting isotopes ([177Lu]Lu-PSMA-617), which penetrate less than 2 mm into tissues, are delivered directly to PSMA-expressing tumor cells, minimizing damage to surrounding tissues. This evidence concerns the gene FOLH1 and neoplasm.